Related Experiment Video
Updated: Feb 6, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Are MicroRNAs Key to Developing Biomarkers for Cutaneous T-Cell Lymphoma?
Maria Estela Martinez-Escala1, Jaehyuk Choi2
1Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Abstract:
MicroRNAs are noncoding molecules that induce epigenetic modulation, and they have been involved in tumorigenesis of solid and hematologic malignancies, including cutaneous T-cell lymphoma. MicroRNAs appear to play a role in cutaneous T-cell lymphoma pathogenesis and in disease progression. We comment on recent efforts to develop microRNA classifiers that improve cutaneous T-cell lymphoma diagnosis and predict disease course.
Insights
MicroRNAs, small noncoding molecules, are implicated in the development and progression of cutaneous T-cell lymphoma. Research is exploring microRNA classifiers for improved diagnosis and disease course prediction.
Area of Science:
- Epigenetics
- Molecular Biology
- Oncology
Background:
- MicroRNAs are noncoding RNA molecules that regulate gene expression.
- They play a role in epigenetic modulation and cellular processes.
- MicroRNAs are implicated in the pathogenesis of various cancers, including hematologic and solid tumors.
Purpose of the Study:
- To review the role of microRNAs in cutaneous T-cell lymphoma (CTCL) pathogenesis.
- To discuss the potential of microRNA-based classifiers for CTCL diagnosis.
- To highlight microRNA's utility in predicting CTCL disease progression.
Main Methods:
- Literature review of recent studies on microRNAs and CTCL.
- Analysis of the involvement of microRNAs in tumorigenesis.
- Evaluation of microRNA classifiers for diagnostic and prognostic applications.
Main Results:
- MicroRNAs are involved in the epigenetic modulation contributing to CTCL development.
- Evidence suggests microRNAs influence CTCL pathogenesis and disease progression.
- MicroRNA classifiers show promise in enhancing CTCL diagnosis and predicting patient outcomes.
Conclusions:
- MicroRNAs are significant players in cutaneous T-cell lymphoma.
- MicroRNA-based approaches offer potential for improved diagnostic accuracy and prognostic prediction in CTCL.
- Further research into microRNA classifiers is warranted for clinical application in CTCL management.
Related Concept Videos
MicroRNAs
MicroRNAs
Key Techniques in Microbiology
Key Elements for Plant Nutrition
Zygotic Development And Stem Cell Formation
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

